Unlocking Youthful Levels Of GH: Embrace Anti-Aging and Vitality Today

This study evaluates the effects of two synthetic growth hormone-releasing peptides (GHRP-2 and Hexarelin) on various hormonal responses, comparing them to other hormonal stimulants. The key findings are:

1. Growth Hormone (GH) Response:

   • Both GHRP-2 and Hexarelin induce a strong, dose-dependent GH response in young adults, which is greater than that elicited by growth hormone-releasing hormone (GHRH) (p < 0.05).

   • In elderly subjects, GH responses to GHRP-2 and Hexarelin are lower than in young subjects (p < 0.01) but still higher than those induced by GHRH (p < 0.05).

2. Prolactin (PRL) Response:

   • GHRP-2 and Hexarelin have a mild PRL-stimulatory effect that is dose-independent and lower than the response to thyrotropin-releasing hormone (TRH) (p < 0.01).

3. Age-Dependent Effects:

   • While GH responses decrease with age, PRL, ACTH, and cortisol responses to GHRP-2 and Hexarelin are not influenced by age.

4. Specificity:

   • The effects of GHRP-2 and Hexarelin are not entirely specific to GH, as they also influence PRL, ACTH, and cortisol levels.

Conclusion:

GHRP-2 and Hexarelin exhibit potent, dose- and age-dependent GH-releasing effects, surpassing the efficacy of GHRH. They also stimulate PRL, ACTH, and cortisol, although these effects are less pronounced for PRL compared to TRH and similar for ACTH/cortisol compared to hCRH. These findings highlight the broader endocrine impact of GHRP-2 and Hexarelin beyond GH stimulation.